We report here three cases of symptomatic intracranial stenosis improved successfully with the administration of cilostazol. Case 1: A 62 year-old man, presented with a TIA due to stenosis of the left middle cerebral artery, was treated immediately with the administration of cilostazol. After three months, 3D-CTA showed improvement of the stenosis. Case 2: A 67 year-old woman, presented with a TIA due to severe stenosis of the basilar artery, was treated immediately with the administration of cilostazol. Cerebral angiography after three weeks showed complete improvement of the stenosis. Case 3: A 69 year-old man, presented with left pontine and cerebellar infarction due to severe stenosis of the basilar artery, underwent percutaneous transluminal angioplasty (PTA) of the basilar artery after the preoperative administration of cilostazol. After six months, 3D-CTA showed no restenosis, and cerebral angiography after twelve weeks showed improvement of the residual stenosis. Cilostazol has not only an antiplatelet effect but also many pleiotropic effects such as a protective effect on endothelial functions, a vasodilating effect, and an inhibition of proliferation on smooth muscle cells. Therefore, cilostazol is effective on the improvement of symptomatic intracranial stenosis, the prevention of restenosis, and the reformation of residual stenosis after PTA.
View full abstract